{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:20:21Z","timestamp":1787941221574,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Program of Hunan Provincial Health Commission","award":["D202303086966"],"award-info":[{"award-number":["D202303086966"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["No.2025JJ80140"],"award-info":[{"award-number":["No.2025JJ80140"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13853-y","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:05:51Z","timestamp":1782277551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying risk factors for adverse drug reactions in HIV\/AIDS patients using LASSO regression modeling"],"prefix":"10.1186","volume":"26","author":[{"given":"Shiqiong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"9","key":"13853_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","volume":"39","author":"MT Angamo","year":"2016","unstructured":"Angamo MT, Chalmers L, Curtain CM, Bereznicki LR. Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors. Drug Saf. 2016;39(9):847\u201357.","journal-title":"Drug Saf"},{"issue":"7","key":"13853_CR2","doi-asserted-by":"publisher","first-page":"e26339","DOI":"10.1002\/jia2.26339","volume":"27","author":"Q Abdool Karim","year":"2024","unstructured":"Abdool Karim Q, Mayer KH, Mohan J, Del Rio C. The audacious goal to end AIDS by 2030: aspiration or reality? J Int AIDS Soc. 2024;27(7):e26339.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"13853_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10461-016-1545-0","volume":"21","author":"H Li","year":"2017","unstructured":"Li H, Marley G, Ma W, Wei C, Lackey M, Ma Q, et al. The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis. AIDS Behav. 2017;21(2):341\u201351.","journal-title":"AIDS Behav"},{"issue":"1","key":"13853_CR4","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.1038\/s41598-024-57900-7","volume":"14","author":"T Darge","year":"2024","unstructured":"Darge T, Babusha A, Chilo D, Dukessa A, Teferi S. Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia. Sci Rep. 2024;14(1):8473.","journal-title":"Sci Rep"},{"issue":"3","key":"13853_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5582\/ddt.2023.01007","volume":"17","author":"H Tanaka","year":"2023","unstructured":"Tanaka H, Satoh M, Takigawa M, Onoda T, Ishii T. Characteristics of adverse event reports among people living with human immunodeficiency virus (HIV) in Japan: Data mining of the Japanese Adverse Drug Event Report database. Drug Discov Ther. 2023;17(3):183\u201390.","journal-title":"Drug Discov Ther"},{"issue":"12","key":"13853_CR6","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1089\/aid.2022.0027","volume":"38","author":"XY Zhou","year":"2022","unstructured":"Zhou XY, Li CX, Zhang JB, Tan JT, Yang X, Albarmaqi RA, et al. Association of Human Leukocyte Antigen Alleles and Hypersensitivity of Efavirenz\/Nevirapine in HIV-Infected Chinese Patients. AIDS Res Hum Retroviruses. 2022;38(12):884\u20139.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"13853_CR7","first-page":"55","volume":"67","author":"YC Lin","year":"2020","unstructured":"Lin YC, Lai YY, Liu HY, Chen YC, Liu LF, Ko NY. [Trends in Immunity and Adverse Drug Reactions Among People Newly Diagnosed With HIV]. Hu Li Za Zhi. 2020;67(1):55\u201365.","journal-title":"Hu Li Za Zhi"},{"issue":"5","key":"13853_CR8","doi-asserted-by":"publisher","first-page":"e0251763","DOI":"10.1371\/journal.pone.0251763","volume":"16","author":"A Sherfa","year":"2021","unstructured":"Sherfa A, Haile D, Yihune M, Sako S. Incidence and predictors of Adverse Drug Reaction (ADR) among adult HIV positive patients on anti-retroviral treatment in Arba Minch town public health facilities, southern Ethiopia: A retrospective cohort study, 2020. PLoS ONE. 2021;16(5):e0251763.","journal-title":"PLoS ONE"},{"key":"13853_CR9","doi-asserted-by":"publisher","first-page":"1721289","DOI":"10.3389\/fphar.2025.1721289","volume":"16","author":"J Sun","year":"2025","unstructured":"Sun J, Qi H, Huang J, Wang Y, Xiang Y, He G, et al. Association of medication regimen complexity index with ADRs in HIV\/AIDS patients: a retrospective cohort study. Front Pharmacol. 2025;16:1721289.","journal-title":"Front Pharmacol"},{"key":"13853_CR10","unstructured":"Therapeutic Goods Administration of department of Health of Australian Government. Note for Guidance on Clinical Safety Data Management Definitions and Standards for Expedited Reporting (CPMP\/ICH\/377\/95) Annotated with TGA Comments. https:\/\/www.tga.gov.au\/sites\/default\/files\/ich37795.pdf."},{"key":"13853_CR11","doi-asserted-by":"crossref","unstructured":"Silva AM, Pereira M, Dias CC, Ventura \u00c2, Sousa-Pinto B. Real-world evidence in antiretroviral therapy: drug safety data. Braz J Infect Dis. 2020 May-Jun;24(3):271\u20132.","DOI":"10.1016\/j.bjid.2020.04.013"},{"issue":"9239","key":"13853_CR12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","volume":"356","author":"A Carr","year":"2000","unstructured":"Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet. 2000;356(9239):1423\u201330.","journal-title":"Lancet"},{"issue":"1","key":"13853_CR13","doi-asserted-by":"publisher","first-page":"18867","DOI":"10.7448\/IAS.16.1.18867","volume":"16","author":"A Jaquet","year":"2013","unstructured":"Jaquet A, Garanet F, Balestre E, Ekouevi DK, Azani JC, Bognounou R, et al. Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso. J Int AIDS Soc. 2013;16(1):18867.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"13853_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12916-022-02639-z","volume":"20","author":"E Haeuser","year":"2022","unstructured":"Haeuser E, Serfes AL, Cork MA, Yang M, Abbastabar H, Abhilash ES, et al. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000\u20132018. BMC Med. 2022;20(1):488.","journal-title":"BMC Med"},{"key":"13853_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.11604\/pamj.2021.38.181.19915","volume":"38","author":"AA Mitkie","year":"2021","unstructured":"Mitkie AA, Bekele FB, Debiso AT. Predictors of adverse drug reaction among adult HIV-infected patients on antiretroviral therapy in government hospitals of Kaffa Zone, Ethiopia; November 2018: a retrospective cohort. Pan Afr Med J. 2021;38:181.","journal-title":"Pan Afr Med J"},{"key":"13853_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1472-6904-12-7","volume":"12","author":"GI Eluwa","year":"2012","unstructured":"Eluwa GI, Badru T, Agu KA, Akpoigbe KJ, Chabikuli O, Hamelmann C. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria. BMC Clin Pharmacol. 2012;12:7.","journal-title":"BMC Clin Pharmacol"},{"issue":"1","key":"13853_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/15376516.2022.2086088","volume":"33","author":"Z Wang","year":"2023","unstructured":"Wang Z, Sun X, Wang B, Shi S, Chen X. Lasso-Logistic regression model for the identification of serum biomarkers of neurotoxicity induced by strychnos alkaloids. Toxicol Mech Methods. 2023;33(1):65\u201372.","journal-title":"Toxicol Mech Methods"},{"key":"13853_CR18","doi-asserted-by":"publisher","first-page":"3001013","DOI":"10.1155\/2022\/3001013","volume":"2022","author":"Y Liu","year":"2022","unstructured":"Liu Y, Shen Y, Wei B. The Clinical Risk Factors of Adenovirus Pneumonia in Children Based on the Logistic Regression Model: Correlation with Lactate Dehydrogenase. Int J Clin Pract. 2022;2022:3001013.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"13853_CR19","doi-asserted-by":"publisher","first-page":"e24061","DOI":"10.1371\/journal.pone.0024061","volume":"7","author":"RM Smyth","year":"2012","unstructured":"Smyth RM, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, et al. Adverse drug reactions in children\u2013a systematic review. PLoS ONE. 2012;7(3):e24061.","journal-title":"PLoS ONE"},{"issue":"4","key":"13853_CR20","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/bcp.12600","volume":"80","author":"EA Saedder","year":"2015","unstructured":"Saedder EA, Lisby M, Nielsen LP, Bonnerup DK, Brock B. Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review. Br J Clin Pharmacol. 2015;80(4):808\u201317.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"13853_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12887-019-1892-x","volume":"20","author":"JP Mouton","year":"2020","unstructured":"Mouton JP, Fortuin-de Smidt MC, Jobanputra N, Mehta U, Stewart A, de Waal R, et al. Serious adverse drug reactions at two children\u2019s hospitals in South Africa. BMC Pediatr. 2020;20(1):3.","journal-title":"BMC Pediatr"},{"issue":"1","key":"13853_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13104-019-4872-1","volume":"13","author":"A Zeleke","year":"2020","unstructured":"Zeleke A, Misiker B, Yesuf TA. Drug-induced hepatotoxicity among TB\/HIV co-infected patients in a referral hospital, Ethiopia. BMC Res Notes. 2020;13(1):2.","journal-title":"BMC Res Notes"},{"issue":"9","key":"13853_CR23","first-page":"276","volume":"90","author":"WO Opiyo","year":"2013","unstructured":"Opiyo WO, Ng\u2019Wena AG, Ofulla AV, Liver function markers and associated serum electrolytes, changes in HIV patients attending patient support centre of Jaramogi Oginga Odinga teaching and referral hospital. Kisumu County, Kenya. East Afr Med J. 2013;90(9):276\u201387.","journal-title":"East Afr Med J"},{"key":"13853_CR24","doi-asserted-by":"publisher","first-page":"204209862311888","DOI":"10.1177\/20420986231188842","volume":"14","author":"L Asio","year":"2023","unstructured":"Asio L, Nasasira M, Kiguba R. Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors. Ther Adv Drug Saf. 2023;14:20420986231188842.","journal-title":"Ther Adv Drug Saf"},{"issue":"5","key":"13853_CR25","doi-asserted-by":"publisher","first-page":"e2411159","DOI":"10.1001\/jamanetworkopen.2024.11159","volume":"7","author":"M Haji","year":"2024","unstructured":"Haji M, Capilupi M, Kwok M, Ibrahim N, Bloomfield GS, Longenecker CT, et al. Clinical Outcomes After Acute Coronary Syndromes or Revascularization Among People Living With HIV: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024;7(5):e2411159.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"13853_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/apc.2022.0192","volume":"37","author":"A Ahmed","year":"2023","unstructured":"Ahmed A, Tanveer M, Dujaili JA, Chuah LH, Hashmi FK, Awaisu A. Pharmacist-Involved Antiretroviral Stewardship Programs in People Living with HIV\/AIDS: A Systematic Review. AIDS Patient Care STDS. 2023;37(1):31\u201352.","journal-title":"AIDS Patient Care STDS"},{"issue":"7","key":"13853_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40266-023-01037-1","volume":"40","author":"D Cattaneo","year":"2023","unstructured":"Cattaneo D, Oreni L, Meraviglia P, Minisci D, Astuti N, Antinori S, et al. Polypharmacy and Aging in People Living with HIV: 6 Years of Experience in a Multidisciplinary Outpatient Clinic. Drugs Aging. 2023;40(7):665\u201374.","journal-title":"Drugs Aging"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13853-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:01:08Z","timestamp":1787940068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13853-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13853"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13853-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Helsinki declaration was adhered to in this study. The study protocol was reviewed and approved by the Ethics Committee of the First Hospital of Changsha (Approval No. KXKX-2020048).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1569"}}